Germany's Merck to buy Bio-Techne for $11.3 billion
Germany's Merck to buy Bio-Techne for $11.3 billion
Thu, June 25, 2026 at 10:26 AM UTC
0
June 25 (Reuters) - Merck KGaA has agreed to acquire biotech firm Bio-Techne Corp for $11.3 billion, the German science and healthcare firm said in a statement on Thursday.
Shares of Bio-Techne rose 22% in premarket trading.
The offer price of $73 per share implies a 24% premium to Bio-Techne's close on Wednesday.
Advertisement
The acquisition would expand Merck's presence in life-science research. Bio-Techne supplies research reagents, proteins, antibodies, analytical instruments and other tools used by scientists and drug developers.
The German firm said it would fund the acquisition through a combination of existing cash and new debt.
(Reporting by Danny Callaghan, Christy Santhosh and Padmanabhan Ananthan; Editing by Linda Pasquini and Shinjini Ganguli)
Source: “AOL Money”
